TET2 and angioimmunoblastic T-cell lymphoma: In addition, DNMT3A mutations are frequently accompanied by TET2 mutations (in 70%~100% of AITL cases), showing synergistic effects on lymphomagenesis despite having opposite epigenetic effects (14).